1. Home
  2. UDMY vs BIOA Comparison

UDMY vs BIOA Comparison

Compare UDMY & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Udemy Inc.

UDMY

Udemy Inc.

HOLD

Current Price

$4.63

Market Cap

716.5M

Sector

Real Estate

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$16.45

Market Cap

681.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UDMY
BIOA
Founded
2009
2015
Country
United States
United States
Employees
N/A
62
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
716.5M
681.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
UDMY
BIOA
Price
$4.63
$16.45
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$9.29
$51.50
AVG Volume (30 Days)
1.6M
371.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
105.36
N/A
EPS
N/A
N/A
Revenue
$789,844,000.00
N/A
Revenue This Year
$4.12
$720.93
Revenue Next Year
$4.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.42
N/A
52 Week Low
$4.02
$4.07
52 Week High
$8.09
$24.00

Technical Indicators

Market Signals
Indicator
UDMY
BIOA
Relative Strength Index (RSI) 47.24 46.53
Support Level $4.23 $15.49
Resistance Level $5.20 $18.26
Average True Range (ATR) 0.30 0.91
MACD -0.01 -0.07
Stochastic Oscillator 46.77 38.17

Price Performance

Historical Comparison
UDMY
BIOA

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Enterprise segment and Consumer segment, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America, and also has its presence in Europe, Middle East, Africa; Asia Pacific; and Latin America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: